Novel human D-amino acid oxidase inhibitors stabilize an active-site lid-open conformation. 2014

Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
*Discovery Research Department, Sunovion Pharmaceuticals, Marlborough, MA 01752, U.S.A.

The NMDAR (N-methyl-D-aspartate receptor) is a central regulator of synaptic plasticity and learning and memory. hDAAO (human D-amino acid oxidase) indirectly reduces NMDAR activity by degrading the NMDAR co-agonist D-serine. Since NMDAR hypofunction is thought to be a foundational defect in schizophrenia, hDAAO inhibitors have potential as treatments for schizophrenia and other nervous system disorders. Here, we sought to identify novel chemicals that inhibit hDAAO activity. We used computational tools to design a focused, purchasable library of compounds. After screening this library for hDAAO inhibition, we identified the structurally novel compound, 'compound 2' [3-(7-hydroxy-2-oxo-4-phenyl-2H-chromen-6-yl)propanoic acid], which displayed low nM hDAAO inhibitory potency (Ki=7 nM). Although the library was expected to enrich for compounds that were competitive for both D-serine and FAD, compound 2 actually was FAD uncompetitive, much like canonical hDAAO inhibitors such as benzoic acid. Compound 2 and an analog were independently co-crystalized with hDAAO. These compounds stabilized a novel conformation of hDAAO in which the active-site lid was in an open position. These results confirm previous hypotheses regarding active-site lid flexibility of mammalian D-amino acid oxidases and could assist in the design of the next generation of hDAAO inhibitors.

UI MeSH Term Description Entries
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D003605 D-Amino-Acid Oxidase dextro-Amino Acid Oxidase,D-Amino Acid Dehydrogenase,Acid Dehydrogenase, D-Amino,Acid Oxidase, dextro-Amino,D Amino Acid Dehydrogenase,D Amino Acid Oxidase,Dehydrogenase, D-Amino Acid,Oxidase, D-Amino-Acid,Oxidase, dextro-Amino Acid,dextro Amino Acid Oxidase
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012694 Serine A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids. L-Serine,L Serine
D016194 Receptors, N-Methyl-D-Aspartate A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity. N-Methyl-D-Aspartate Receptor,N-Methyl-D-Aspartate Receptors,NMDA Receptor,NMDA Receptor-Ionophore Complex,NMDA Receptors,Receptors, NMDA,N-Methylaspartate Receptors,Receptors, N-Methylaspartate,N Methyl D Aspartate Receptor,N Methyl D Aspartate Receptors,N Methylaspartate Receptors,NMDA Receptor Ionophore Complex,Receptor, N-Methyl-D-Aspartate,Receptor, NMDA,Receptors, N Methyl D Aspartate,Receptors, N Methylaspartate
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic

Related Publications

Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
June 2018, Bioorganic & medicinal chemistry letters,
Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
January 2019, Molecules (Basel, Switzerland),
Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
July 1980, The Journal of biological chemistry,
Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
May 2006, Journal of biochemistry,
Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
May 1997, Biochemistry,
Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
October 1976, The Journal of biological chemistry,
Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
August 1980, Proceedings of the National Academy of Sciences of the United States of America,
Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
January 1980, The Journal of biological chemistry,
Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
January 2007, Chemical record (New York, N.Y.),
Ryan T Terry-Lorenzo, and Lawrence E Chun, and Scott P Brown, and Michele L R Heffernan, and Q Kevin Fang, and Michael A Orsini, and Loredano Pollegioni, and Larry W Hardy, and Kerry L Spear, and Thomas H Large
January 2017, Frontiers in molecular biosciences,
Copied contents to your clipboard!